258 related articles for article (PubMed ID: 20678090)
21. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Sampaio EP; Malta AM; Sarno EN; Kaplan G
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
[TBL] [Abstract][Full Text] [Related]
22. [Late-occurring cutaneous vasculitis after successful treatment of diffuse lepromatous leprosy: Lucio's phenomenon].
Fenniche S; Benmously R; Sfia M; Daoud L; Debbiche A; Ben Ayed M; Mokhtar I
Med Trop (Mars); 2007 Feb; 67(1):65-8. PubMed ID: 17506277
[TBL] [Abstract][Full Text] [Related]
23. Multibacillary leprosy mimicking systemic lupus erythematosus: case report and literature review.
Horta-Baas G; Hernández-Cabrera MF; Barile-Fabris LA; Romero-Figueroa Mdel S; Arenas-Guzmán R
Lupus; 2015 Sep; 24(10):1095-102. PubMed ID: 25761657
[TBL] [Abstract][Full Text] [Related]
24. Lest we forget Hansen's disease (leprosy): an unusual presentation with an acute onset of inflammatory polyarthritis and the rheumatology experience.
Sheetal S; Arvind C
Int J Rheum Dis; 2009 Apr; 12(1):64-9. PubMed ID: 20374320
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
26. Facial tuberculoid leprosy: case report.
Ali K; Sittampalam G; Malik MA
Br J Oral Maxillofac Surg; 2011 Jan; 49(1):70-2. PubMed ID: 20188445
[TBL] [Abstract][Full Text] [Related]
27. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
Armour KS; Scolyer RA; Barnetson RS
Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
[TBL] [Abstract][Full Text] [Related]
28. Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.
Ebenezer GJ; Job A; Abraham S; Arunthathi S; Rao PS; Job CK
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):292-7. PubMed ID: 10575409
[TBL] [Abstract][Full Text] [Related]
29. Clinical pilot study: Clarithromycin efficacy in multibacillary leprosy therapy.
Gunawan H; Sasmojo M; Putri HE; Avriyanti E; Hindritiani R; Suwarsa O
Int J Mycobacteriol; 2018; 7(2):152-155. PubMed ID: 29900892
[TBL] [Abstract][Full Text] [Related]
30. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
Vijayakumaran P; Manimozhi N; Jesudasan K
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
[TBL] [Abstract][Full Text] [Related]
31. Atypical Hansen's disease presenting as florid verrucous plaques on the lower extremities: a case report.
Yuchua-Guillen A; Dofitas BL
Int J Dermatol; 2012 Jun; 51(6):697-701. PubMed ID: 22607288
[TBL] [Abstract][Full Text] [Related]
32. Childhood leprosy in a tertiary-care hospital in Delhi, India: a reappraisal in the post-elimination era.
Singal A; Sonthalia S; Pandhi D
Lepr Rev; 2011 Sep; 82(3):259-69. PubMed ID: 22125934
[TBL] [Abstract][Full Text] [Related]
33. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
34. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
Lepr Rev; 1996 Dec; 67(4):260-79. PubMed ID: 9033197
[TBL] [Abstract][Full Text] [Related]
35. Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines.
Maghanoy A; Mallari I; Balagon M; Saunderson P
Lepr Rev; 2011 Mar; 82(1):65-9. PubMed ID: 21644473
[TBL] [Abstract][Full Text] [Related]
36. Clinical-pathological conference: case 3.
Hall JM; Torske KR; Kahn MA; Moreland AA; Moschella SL
Head Neck Pathol; 2010 Sep; 4(3):226-9. PubMed ID: 20676829
[No Abstract] [Full Text] [Related]
37. Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
Asz-Sigall D; López-García L; Neme-Yunes Y; Yuen-Palos R; Vega-Memije ME; Arenas R
Int J Dermatol; 2008 Oct; 47(10):1084-6. PubMed ID: 18986365
[No Abstract] [Full Text] [Related]
38. Sub-polar lepromatous leprosy localized to the face.
George M; Rajan U; George S; Pakran J; Thomas S
Dermatol Online J; 2010 Sep; 16(9):8. PubMed ID: 20875329
[TBL] [Abstract][Full Text] [Related]
39. A case report of osteogenic sarcoma with leprosy.
Bajpai J; Shetty N; Gupta A; Samar A; Kelkar R
J Cancer Res Ther; 2013; 9(2):311-3. PubMed ID: 23771385
[TBL] [Abstract][Full Text] [Related]
40. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]